Clinical Trials Logo

Clinical Trial Summary

To evaluate analgesic onset, efficacy, and safety of 1000 mg acetaminophen administered as two Test Acetaminophen 500 mg tablets (Test ACM) compared with 1000 mg acetaminophen administered as two commercial acetaminophen 500 mg caplets (ACM) and 400 mg ibuprofen administered as two commercial ibuprofen 200 mg liquid-filled capsules (IBU) in the dental pain model following third-molar extractions.


Clinical Trial Description

This is a single-dose, randomized, double-blind, placebo- and active- controlled, parallel-group study to evaluate the analgesic onset, efficacy, and safety profile of Test ACM 1000 mg compared with two commercial products over a four-hour period after third-molar extractions. Subjects will undergo dental extraction of three or four third molars. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03224403
Study type Interventional
Source Johnson & Johnson Consumer and Personal Products Worldwide
Contact
Status Completed
Phase Phase 3
Start date July 19, 2017
Completion date April 12, 2018

See also
  Status Clinical Trial Phase
Completed NCT03566979 - Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain Phase 3